|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
July 22, 2026 TOP NEWS War update: CENTCOM assets targeted Iranian
military operations centers, maritime capabilities, aircraft hangars, drone
storage facilities, and military logistics infrastructure to further degrade
Iran's ability to threaten commercial shipping in the Strait of Hormuz. Iran
said it targeted U.S. assets in Kuwait, Bahrain and Jordan and a vessel in
the Strait of Hormuz on Tuesday. Gift nifty indicates a 50
points cut on bourses where as
Asian markets are flaring well. Canara Robeco AMC Q1 FY27: Revenue Hits
₹1,162 Mn, PAT Soars 83% QoQ | MCap 5,284.56 Cr -
Revenue from Operations: ₹1,162 Mn, up 20% YoY and 2% QoQ. - Profit After
Tax: ₹756 Mn, up 24% YoY and 83% QoQ. - Total Expenses: ₹464 Mn, up 12% YoY
and down 2% QoQ. - Employee Benefit Expenses: ₹281 Mn, up 19% QoQ and 13%
YoY. - Total AUM as of June 30, 2026: ₹1,195 billion, up 2% YoY. - QAAUM:
₹1,187 billion, up 7% YoY. - Equity-oriented QAAUM: ₹1,081 billion, up 7%
YoY. - Total folio count: 5.05 million as of June 30, 2026. Cyient DLM: Revenue was up by 34% yoy to Rs 374 cr. EBITDA was up by 56% yoy to Rs 39 cr. PAT was double to Rs 16 cr vs Rs 7 cr in Q1FY26. The
company closed the quarter with its highest ever order book of 2,598 crores
(25,989 million), and a healthy order inflow of 551.9 crores resulted in a
book-to-bill ratio of 1.5x, with 70% from existing and 30% from new
customers. The company expects to maintain strong momentum in Q2 and beyond,
targeting a full-year book-to-bill ratio of 1.5x.
During the Expand phase (FY27-FY29), Cyient DLM
aims to achieve EBITDA margins of 11-13% by focusing on robotics, AI data
centers, and semiconductor equipment. IHC: Revenue at Rs 2,339 cr up 14.6% YoY. EBITDA was up by 17% yoy
to Rs 672 crore. PAT was up by 19% to Rs 391 crore. RevPAR growth in domestic
like-for-like hotels was 14% YoY. Occupancy improved to 82% vs 76% in 1QFY26.
Signed 20 hotels and opened 11 hotels with 700 keys during the quarter. Total
portfolio reached to 645 hotels with 66,209 keys,
including 264 hotels and 32,600 keys in pipeline as of Jun’26. Trump Announces Upto
200% Tariffs On Generic Drugs, Move May Impact
India: The United States has announced steep tariffs on imported generic
drugs from August 2028. The move, according to US President Donald Trump, was
aimed at onshoring production of such pharmaceutical products. The move is
likely to affect India -- the largest exporter of generic drugs to the US.
Taking to his Truth Social platform, Trump said the phased tariff plan will
come into effect from August 1, and for the first two years, the United
States will continue to have a zero per cent tariff on all generic drugs
brought into the country. For the third year, the tariff will be raised to
100 per cent, and it will be 200 per cent thereafter, he said. View Will
await further clarity but my quick sense is hoping
that the manufacture being referred to is not all the drugs but having manufacturing
units in the US (just like how the policy was for branded drugs). Most
companies have some units (organically or in
organically) there and 2 years provides enough time to meet the rules.
Additionally, in the last such move, branded drug companies subsequently entered into deals with the government to circumvent the
impact of tax and same can be sought by generic companies too. However, will
wait to see how market responds to this new tariff. The news is
sentimentally negative as investors could turn risk averse in the near term
as they await clarity. Key companies to watch out for
: dr reddys, Zydus, Aurobindo Pharma Anant Raj Limited: Anant Raj’s board has
approved a strategic demerger to create two independently listed
companies—Anant Raj Limited, focused on real estate and infrastructure, and
Ashok Cloud Pvt. Ltd., dedicated to data centres,
cloud services, and AI-ready digital infrastructure. The restructuring aims
to unlock shareholder value, provide independent management focus, and enable
investors to separately value the fast-growing digital infrastructure
business. Eligible Anant Raj shareholders will receive one equity share of
Ashok Cloud for every one Anant Raj share held (1:1 share entitlement) upon
the scheme becoming effective. Bandhan Bank: Profit zooms 35% to Rs 501.7
crore Vs Rs 372 crore: Net interest income increases 5.9% to Rs 2,920.6 crore
Vs Rs 2,757.2 crore. Provisions and contingencies plunge 40.5% to Rs 682.6
crore Vs Rs 1,146.9 crore. Gross NPA fall to 3.15%
Vs 3.27% (QoQ). Net NPA declines to 0.93% Vs 0.97% (QoQ). AAVAS Financiers Q1 (YoY): Profit jumps 23%
to Rs 171.3 crore Vs Rs 139.2 crore. Net interest income soars 16.7% to Rs
323.8 crore Vs Rs 277.6 crore. TVS Holdings Q1 (Consolidated YoY): Profit
surges 73.8% to Rs 1,173.6 crore Vs Rs 675.4 crore. Revenue soars 34% to Rs
17,076.2 crore Vs Rs 12,742.2 crore. PREVIEW:
MACRO
WRAP
INVESTMENT
CALLS First Cut: Sagility Ltd: Revenue in line and guidance maintained
First Cut: Sunteck
Realty Q1FY27 Consolidated Results – Pre-sales Momentum Continues. ·
Pre-sales
increased 19.8% YoY to Rs.787 crore, driven by steady demand across ongoing
premium and mid-income projects. Collections increased 16.5% YoY to Rs.409
crore. ·
Consolidated
revenue stood at Rs.192 crore, up 1.7% YoY, EBITDA grew 40.3% YoY to Rs.67
crore, while EBITDA margin expanded by 962 bps YoY to 35%. ·
Net profit rose
26.5% YoY to Rs.42.3 crore. ·
We will release
detailed report soon. Results (Consolidated)
Rs cr.
Stock Update: UltraTech Cement Ltd– Strong Q1; Growth trajectory intact Reco:
BUY
CMP: Rs. 11,898
Target:
14,200
Viewpoint: Oberoi Realty Ltd– Launch momentum stays strong View:
Positive
CMP: Rs. 1,880
Target:
2,122
OTHER NEWS Maruti Suzuki India: Due to the continuous
increase in input costs, the company has decided to increase the prices of
its models across the portfolio by up to Rs 30,000. The price hike will come
into effect in August 2026 Aditya Birla Capital: The company has made an investment of Rs 123.89 crore, on a rights basis, in the equity shares of its associate, Aditya Birla Health Insurance Company. Following this investment, there will be no change in Aditya Birla Capital's percentage shareholding, and Aditya Birla Health Insurance Company will continue to remain an associate of the company |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||